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Few studies have examined associations of inhalant use and inhalant use 
disorders (IUDs) to suicide ideation and attempts. We investigated these relation- 
ships in the largest comorbidity survey conducted in the United States. Suicidal 
ideation was significantly more prevalent among inhalant users than nonusers and 
severity of inhalant use problems was positively related to suicidal ideation. 
Among persons with IUDs, 67.4% had thought about committing suicide and 
20.2 % had attempted suicide. Multivariate logistic regression analyses indicated 
that respondents with IUDs reported significantly higher levels of suicide ideation 
than inhalant nonusers. Inhalant use is associated with significantly increased risk 
for suicide ideation, especially among women and persons with DSM-IV IUDs. 
Psychiatric disorders are associated with in- 
creased risk for suicidal behavior. A psychiat- 
ric diagnosis is present in 90% or more of 
deaths from suicide in western countries in- 
cluding the United States (Bertolote, Fleisch- 
mann, De Leo, & Wasserman, 2004). Of psy- 
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chiatric disorders, substance use disorders are 
among the strongest known risk factors for 
completed suicide (Wilcox, Conner, & Caine, 
2004). According to a review of cohort stud- 
ies, individuals with alcohol dependence are 
at 9.8 (CI: 9.0 to 10.7) times greater risk to 
die by suicide compared to the general popu- 
lation, and persons with other drug use disor- 
ders are at 13.7 (CI: 10.3 to 18.0) times 
greater risk (Wilcox et al., 2004). Substance 
use disorders are also highly predictive of sui- 
cidal thoughts, plans, and nonfatal attempts 
(Borges, Walters, & Kessler, 2000; Wilcox & 
Anthony, 2004). Substance use may directly 
induce lower serotonergic central nervous 
system activity and produce dysfunction in 
the ventral prefrontal cortex, an area respon- 
sible for inhibition of aggressive impulses (in- 
cluding suicide attempts). Substance use may 
also contribute indirectly to suicide risk via 
precipitation of psychosocial crises and con- 
sequent feelings of dysphoria and hopeless- 
ness (Mann, 2003). 
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Relatively few studies have examined 
suicide risk in relation to specific psychoac- 
tive substances of abuse, but available reports 
suggest that inhalants may be unique in 
terms of the frequency and degree to which 
their use is associated with enhanced risk for 
suicide ideation and attempts-especially among 
girls and women (Luncheon, Bae, Gonzalez, 
Lurie, & Singh, 2008; Wilcox & Anthony, 
2004). Borges et al. (2000) assessed the rela- 
tionship of substance use, abuse without de- 
pendence, and dependence to risk for subse- 
quent first suicide attempt across ten classes 
of psychoactive agents assessed in the Na- 
tional Comorbidity Survey. Adjusted odds 
ratios (ORs) comparing inhalant users (OR = 
1.9, CI: 1.0 to 3 . 9 ,  inhalant abusers (OR= 
10.0, CI: 2.8 to 35.0), and persons with inhal- 
ant dependence (OR = 6.8, CI: 2.4 to 18.8) to 
inhalant nonusers were substantial and statis- 
tically significant. Inhalant dependence was 
more strongly related to suicide attempts 
than any other type of substance dependence; 
similar findings were noted for inhalant abuse 
compared to other forms of substance abuse. 
Inhalant use without abuse or dependence 
posed a significant risk for suicide attempt 
but at a level similar to most other forms of 
substance use, suggesting that inhalant abuse 
and dependence may be relatively specific 
markers of elevated risk for suicide attempts. 
In one of few longitudinal studies, 
Wilcox and Anthony (2004) did not find on- 
set of alcohol or tobacco use prior to age 16 
significantly associated with later risk for sui- 
cide attempt or ideation in a large sample of 
youth followed from first grade into young 
adulthood. However, onset of inhalant use 
prior to age 16 was a significant risk factor 
for suicide attempt (Relative Risk [RR] = 2.2) 
and suicide ideation (RR = 2.9) for girls, but 
not boys. Freedenthal et al. (2007) reported 
that in a sample of incarcerated adolescents, 
inhalant use was significantly related to sui- 
cidal ideation in girls but not boys, whereas 
boys and girls with formal IUDs had signifi- 
cantly elevated rates of suicide ideation and 
attempts compared to inhalant nonusers in 
their study of 723 antisocial adolescents. Sa- 
kai, Hall, Mikulich-Gilbertson, and Crowley 
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(2004) identified significantly elevated rates 
of lifetime suicide attempt among adolescent 
inhalant users with and without DSM-IV 
IUDs (32% vs. 27%, respectively) compared 
to inhalant nonusers (1.5%), but the differ- 
ence between inhalant users with and without 
IUDs in lifetime suicide attempt prevalence 
was not statistically significant. 
There are several possible explanations 
for reported findings identifymg significant 
associations between inhalant use, IUDs and 
suicide ideation and attempts. Inhalation of 
gasoline, glue, and other neurotoxic inhalants 
can produce an acute intoxication syndrome 
similar to that produced by alcohol, includ- 
ing signs such as slurred speech, ataxia, and 
stupor or coma. Onset of intoxication occurs 
rapidly and may disinhibit cortical circuits 
regulating expression of self-injurious and 
other impulsive behaviors. Thus, acute inhal- 
ant intoxication may contribute to suicidal 
ideation and/or impulsive suicide attempts on 
the part of people experiencing such ideation. 
Persistent neurological and cognitive impair- 
ments predisposing to suicidal ideation and 
suicide attempts may follow repeated use of 
neurotoxins, such as that which occurs in 
IUDs. It is also possible that persons experi- 
encing heightened levels of depression or 
anxiety may “self-medicate” with inhalants, 
which are reported by some users to have 
anxiolytic and euphorogenic effects (Perron, 
Vaughn, & Howard, 2007). Finally, inhalant 
use/IUDs and suicide ideatiodattempts may 
share common origins in factors increasing 
risk for both sets of conditions, including low 
socioeconomic status and mood, anxiety, and 
personality disorders. That is, the association 
may be noncausal and attributable to third- 
factors that increase risk for both sets of dis- 
orders. 
The availability of a large, nationally 
representative survey incorporating assess- 
ments of inhalant use, IUDs, suicide ideation 
and attempts, and relevant sociodemographic 
covariates enabled our team to explore rela- 
tionships among these variables in the largest 
comorbidity study conducted in the United 
States. Although Borges et al.2 (2000) and 
Sakai et al.’s (2004) results suggest that inhal- 
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ant users evidence greater suicidality than in- 
halant nonusers, it remains unclear whether 
and to what extent inhalant users who prog- 
ress to formal IUDs are at greater risk for 
suicidal ideation and attempts than inhalant 
users without IUDs. Thus, we hypothesized 
that inhalant users without IUDs would evi- 
dence significantly greater prevalence of sui- 
cide ideation and attempts than inhalant 
nonusers, but significantly lower prevalence 
of suicide ideation and attempts than adults 
with IUDs. That is, we expected that prob- 
lematic involvement with inhalants would 
display a graded relationship to suicide ide- 
ation and attempts and that these relation- 
ships would be stronger in women than men. 
METHODS 
Subjects 
Study findings are based on data from 
the 2001-2002 National Epidemiologic Sur- 
vey on Alcohol and Related Conditions 
(NESARC). NESARC is a nationally repre- 
sentative survey of 43,093 noninstitutional- 
ized U.S. residents aged 18 years and older 
(Grant, Dawson, Stinson, Chou, Kay, & 
Pickering, 2003). The survey gathered infor- 
mation on alcohol use and comorbid condi- 
tions from individuals living in household 
and group settings such as shelters, college 
dormitories, and group homes. 
NESARC utilized a multistage cluster 
sampling design, oversampling young adults, 
Hispanics, and African Americans in the in- 
terest of obtaining reliable statistical estima- 
tion in these populations, and to ensure ap- 
propriate representation of racial and ethnic 
subgroups, with an overall response rate of 
81%. Data were weighted at the individual 
and household level and to adjust for over- 
sampling and nonresponse on demographic 
variables. Data were also adjusted to be rep- 
resentative (viz., region, age, race, and eth- 
nicity) of the U.S. adult population based on 
the 2000 Census. 
Measures 
Face-to-face interviews were conducted 
by U.S. Census Bureau workers trained by 
the National Institute on Alcohol Abuse and 
Alcoholism. Interviewers administered the 
Alcohol Use Disorder and Associated Disa- 
bilities Interview Schedule-DSM-IV version 
(AUDADIS-TV), shown to have good reli- 
ability in assessing alcohol and drug use in 
the general population (Grant, Harford, Daw- 
son, Chou, & Pickering, 1995). 
Participants in this study included life- 
time inhalant nonusers and users (i.e., re- 
spondents who answered affirmatively to the 
question, “Have you ever used inhalants or 
solvents, for example, amyl nitrite, nitrous 
oxide, glue, toluene, or gasoline?”). An intro- 
ductory statement preceding the inhalant as- 
sessment item ensured that respondents were 
informed that they were to report inhalants 
used on their own, without a doctor’s pre- 
scription, and for the purposes of getting 
high, enjoying themselves, relaxing, feeling 
better, feeling more alert, quieting their 
nerves, or seeing how they would work. 
Within the sample of lifetime inhalant users, 
“inhalant abuse” diagnoses were assigned to 
respondents who met DSM-IV inhalant abuse 
criteria only, and “inhalant dependence’’ di- 
agnoses were assigned to adults who met 
DSM-IV inhalant dependence criteria (Ameri- 
can Psychiatric Association, 2000). In this 
study, respondents were classified as inhalant 
nonusers if they reported no lifetime inhalant 
use, inhalant users (IUD-) if they reported 
lifetime inhalant use but had never met 
DSM-IV inhalant abuse or inhalant depen- 
dence criteria, or as inhalant users with IUDs 
(IUD+) if they reported inhalant use and met 
lifetime criteria for either inhalant abuse or 
dependence. Inhalant users meeting inhalant 
abuse or dependence criteria were combined 
into one group of respondents (IUD+) to 
maximize statistical power for group con- 
trasts. 
NESARC participants completed sui- 
cide ideation and attempt items if they re- 
sponded affirmatively to one or both of two 
items assessing lifetime low mood and anhe- 
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donia. The questions were: “In your entire 
life, have you ever had a time when you felt 
sad, blue, or down most of the time for at 
least 2 weeks?” and “In your entire life, have 
you ever had a time, lasting at least 2 weeks, 
when you didn’t care about the things that 
you usually cared about, or when you didn’t 
enjoy the things you usually enjoyed?” Over- 
all, 13,733 (32%) respondents reported at 
least one lifetime episode of low mood and/ 
or anhedonia; approximately 66% of those 
were women and the sample averaged 45.9 
(SO = 17.2) years of age. Suicide-specific ques- 
tions asked whether respondents had ever at- 
tempted suicide, thought about committing 
suicide, felt like they wanted to die, or thought 
a lot about their own death during a period 
of low mood. These questions were answered 
either “yes” or “no.” 
Alcohol use disorder diagnoses in- 
cluded lifetime alcohol abuse and alcohol de- 
pendence and were assigned in accordance 
with DSM-IV specifications. Likewise, anti- 
social personality disorder, anxiety disorders 
(which included panic disorder, agoraphobia, 
social and specific phobias, and generalized 
anxiety disorder), mood disorders (i.e., life- 
time mania, hypomania, dysthymia, and ma- 
jor depressive disorder), and non-inhalant 
drug use disorders (i.e., lifetime abuse or de- 
pendence on heroin, hallucinogens, cocaine/ 
crack, marijuana, stimulants, painkillers, tran- 
quilizers, and sedatives) were also assigned 
consistent with DSM-IV guidelines. Race, 
gender, age, marital and educational status, 
and annual personal income were included as 
covariates with response categories indicated 
in tabled results. 
Analytic procedures 
Weighted prevalence estimates and 
95% confidence intervals were computed us- 
ing SUDAAN Version 9.0 (Research Trian- 
gle Institute, 2004). This system implements 
a Taylor series linearization to adjust stan- 
dard errors of estimates for complex survey 
sampling design effects. Multivariate logistic 
regression analyses were conducted with si- 
multaneous entry of covariates listed in the 
far left columns of tabled results. Adjusted 
odds ratios (AORs) and 95% confidence in- 
tervals are presented to reflect association 
strength and significance. 
RESULTS 
Characteristics of Inhalant Nonusers 
and IUD- and IUD+ Inhalant Users 
Comparisons of inhalant nonusers and 
IUD- and IUD+ respondents revealed sig- 
nificant differences across measures of gen- 
der, age, marital status, and lifetime DSM-IV 
diagnoses of antisocial personality disorder, 
anxiety disorders, mood disorders, and alco- 
hol and non-inhalant drug use disorders (Ta- 
ble 1). In general, IUD-- and IUD+ users 
were significantly younger, more likely not to 
have married, and more likely to meet anti- 
social personality, anxiety, mood, and non- 
inhalant substance use disorder criteria, than 
inhalant nonusers. 
Approximately seven-in-ten IUD- re- 
spondents were male, half were between ages 
18 and 34, one third met antisocial personal- 
ity disorder criteria, half evidenced a lifetime 
anxiety disorder, three quarters met lifetime 
mood disorder criteria, and more than four 
in five met criteria for lifetime alcohol and 
non-inhalant drug use disorders. IUD+ re- 
spondents tended to be disproportionately 
male and had significantly higher rates of 
lifetime antisocial personality disorder and 
non-inhalant drug use disorders and equiva- 
lently high rates of alcohol use disorders and 
mood disorders compared to IUD- respon- 
dents. 
Suicide Ideation and Attempts among 
Inhalant Nonusers and IUD- 
and IUD+ Respondents 
Significant group differences were 
identified between inhalant-nonusing, IUD-, 
and IUD+ respondents across all measures of 
suicide ideation and attempt in the total 
NESARC sample assessed for suicidality (Ta- 
ble 2). Specifically, IUD- respondents re- 
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TABLE 1 
Characteristics of NESARC Participants Completing Suicide Items, Overall and by Inhalant 
Use Subgroup 
Variable 
Inhalant Subgroup comparison 
Inhalant 
Overall Non-users IUD- IUD+ 























Personal income, $/y 
20,000-34,999 
3 5,000-69,999 
Antisocial personality disorder 





















Yes 34.80 (.69) 
No 65.20 (.69) 
Yes 61.4 (.66) 
No 38.60 (.66) 
Yes 38.52 (.79) 
No 61.48 (.79) 
Lifetime DSM-IV Mood Disorder 
Lifetime DSM-ZV alcohol use disorder 
Lifetime DSM-ZV non-inhal- 
ant drug use disorder 
Yes 16.44 (54) 




















69.51 (3.23) 75.82 (5.14) .OOOWb 
30.49 (3.23) 24.18 (5.14) 
51.14 (3.37) 40.64 (5.92) .OOOOab 
43.91 (3.39) 54.69 (5.95) 
4.95 (1.31) 4.67 (2.19) 
81.88 (2.93) 80.77 (4.43) .0977 
18.12 (2.93) 19.23 (4.43) 
42.19 (3.58) 39.90 (5.85) .OOOOab 
18.92 (2.86) 22.29 (4.33) 
38.17 (3.38) 37.81 (5.73) 
14.44 (2.73) 21.01 (5.33) .7977 
27.24 (3.55) 27.92 (5.28) 
58.32 (4.16) 51.08 (5.90) 
29.51 (3.27) 34.42 (6.38) .4941 
20.92 (2.66) 18.21 (4.21) 
32.14 (3.58) 26.23 (6.07) 
17.43 (2.94) 21.14 (5.38) 
33.96 (3.70) 56.77 (6.24) .000OabC 
66.04 (3.70) 43.23 (6.24) 
34.34 (.69) 50.01 (3.67) 44.63 (6.33) .0003b 
65.66 (.69) 49.99 (3.67) 55.37 (6.33) 
60.90 (.67) 74.77 (2.96) 83.83 (4.25) .000Wb 
39.10 (.67) 25.23 (2.96) 16.17 (4.25) 
36.93 (.78) 87.89 (2.63) 87.36 (4.27) .OOOOab 
63.07 (.78) 12.11 (2.63) 12.64 (4.27) 
14.24 (51) 81.43 (2.83) 94.54 (2.62) .OOOOab' 
85.76 (51) 18.57 (2.83) 5.46 (2.62) 
Notes. *All Ns in column headings are unweighted values. All table values are weighted column 
percentages (standard errors). IUD- refers to inhalant users without lifetime DSM-ZV inhalant abuse 
or dependence. IUD+ refers to inhalant users with DSM-ZV lifetime inhalant abuse or de endence. 
tTests of differences based on chi-square. In some cases, cell totals may not equaI!100% due 
to rounding error. Bonferroni-corrected value = .05/10 = .005. 
'Painvise ost-hoc contrasts for inftalant nonusers vs. inhalant users with DSM-ZV inhalant use 
disorders (IUD+! All significant a contrasts were significant a t  
bPairwise ost hoc contrasts for inhalant nonusers vs. in alant users without DSM-ZV inhalant 
use disorders (ISD-,. All significant contrasts were significant at p < .001. 
'Painvise post-hoc contrasts for inhalant users without inhalant use disorders (IUD-) vs. inhal- 
ant users with inhalant use disorders (IUD+). The contrasts for antisocial personality disorder and 
noninhalant drug use disorders were significant a t  p < .01. 
R < .OO1. 
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TABLE 2 
Proportions of NESARC Respondents with a History of  Suicide Attempts and Ideation, Overall 
and by Inhalant Use Subgroups 
Inhalant User Subgroup Comparisons 
Inhalant Non-users IUD- IUD+ 
Total, N =  13,180 Total, N =  284 Total, N= 88 
Overall Males, n = 4,379 Males, n = 185 Males, n = 63 















Thought a lot about 




7.48 (.28) 7.12 (.27) 
6.49 (.46) 5.78 (.43) 
8.08 (.33) 7.90 (.33) 
26.38 (.64) 25.68 (.62) 
26.31 (38) 24.81 (.87) 
26.43 (.71) 26.19 (.70) 
32.35 (.60) 31.69 (59) 
29.35 (24) 27.87 (.83) 
34.19 (.74) 33.93 (.73) 
25.41 (.48) 24.92 (.47) 
25.69 (.74) 24.90 (.75) 













20.15 (4.46) .0002"'b 
16.73 (5.03) .OOITb 
30.85 (10.41) .019Pb 
67.42 (6.17) .OOOOqb'" 
65.25 (7.19) .000OaVb 
74.21 (10.02) .OOO1a'b 
66.90 (5.45) .00002b' 
63.66 (6.91) .OOOOqb 
77.01 (9.2 1) .0003"b 
55.13 (6.49) .OOOO".b'' 
58.39 (7.53) .0009"b'' 
44.95 (12.07) .OO1lb 
Notes. All Ns in column headings are unweighted values. Table values are weighted column per- 
centages (standard errors). IUD- refers to lifetime inhalant users without lifetime DSM-IV inhalant 
abuse or dependence. IUD+ refers to inhalant users with DSM-IVlifetime inhalant abuse or dependence. 
tTests of differences based on x2. The Bonferroni-adjusted p value was . O W 2  = .004. 
'Painvise post-hoc contrasts for inhalant nonusers vs. inhalant users with DSM-ZV inhalant use 
disorders (IUD+). For total sample, all a contrasts were significant at p < .001, except suicide attempt (p 
< .Ol). For males, thought about committing suicide and felt like you wanted to die were significant a t  
p < .001, thought a lot about your own death at p < .01, and suicide attempt a t  p < .05. For females, 
thought about committing suicide and felt like you wanted to die were significant a t p  < .01, and suicide 
attempt was significant a t  p < .05. 
bPainvise post-hoc contrasts for inhalant nonusers vs. inhalant users without DSM-ZV inhalant 
use disorders (IUD-). All such contrasts for the total sample were significant at p < .001. For men, 
thought about committing suicide and felt like you wanted to die were significant at p < .001, suicide 
attempt a t  p < .01, and thought a lot about your own death at p < .05. For females, thought about com- 
mitting suicide and thought a lot about your own death were significant a t p  < .001, felt like you wanted 
to die a t  p < .01, and suicide attempt at p < .05. 
'Painvise post-hoc contrasts for inhalant users without inhalant use disorders (IUD-) vs. inhalant 
users with inhalant use disorders (IUD+). All significant contrasts for the total sample were significant 
at p < .05. For males, thought a lot about your own death was significant at p = .01. For females, no post 
hoc contrasts were statistically significant; p values ranged from .10 to .22 for the variables in the first 
three rows of Table 2,  suggesting that low statistical power may have been a factor in the failure to 
detect significant IUD- vs. IUD+ in women across measure of suicide despite apparently moderate-to- 
large effects. 
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ported significantly higher lifetime preva- 
lence rates of thinking about suicide, feeling 
like they wanted to die, and thinking a lot 
about their own death than inhalant nonus- 
ers, but Significantly lower rates of suicide 
ideation compared to IUD+ respondents. 
The prevalence of suicide ideation was very 
high (55%-67%) for IUD+ respondents 
across all three measures. IUD+ women re- 
ported higher rates of thinking about com- 
mitting suicide and feeling like they wanted 
to die than IUD+ men, whereas IUD+ men 
were more likely to report thinking a lot 
about their own death than IUD+ women. 
IUD- and IUD+ respondents exhib- 
ited significantly elevated rates of one or 
more lifetime suicide attempts compared to 
inhalant nonusers, although differences be- 
tween IUD- and IUD+ respondents were 
not substantial overall or for men. Nearly 
one-in-three IUD+ women reported a life- 
time suicide attempt compared to fewer than 
one-in-five IUD- women and one-in-thir- 
teen women who were inhalant nonusers, al- 
though these differences did not attain statis- 
tical significance due to low power. Thus, for 
all three measures of suicide ideation among 
women, there was bivariate evidence of an 
monotonic association between extent of 
problematic involvement with inhalants and 
suicidal thoughts. Inhalant users evidenced 
significantly higher rates of suicide attempts 
than did nonusers. 
Multivariate Logistic Regression 
Prediction of Suicide Ideation 
and Attempts 
Multivariate logistic regression was used 
to examine associations between inhalant use 
and each suicide ideation and attempt mea- 
sure, while adjusting for other sociodemo- 
graphic and clinical variables. The results in- 
dicated that IUD+ but not IUD- respondents 
were significantly more likely to report sui- 
cidal ideation compared to inhalant nonusers. 
Neither IUD- or IUD+ respondents exhib- 
ited a significantly higher likelihood of re- 
porting actual suicide attempts compared to 
inhalant nonusers. 
Other factors associated with suicide 
ideation and attempts included being female; 
younger; separated; divorced, or widowed; 
currently married or cohabitating (inversely 
associated); having lower annual incomes and 
less education, and having met criteria for 
antisocial personality, anxiety, mood, alcohol 
use, and non-inhalant drug use disorders. It 
is notable that even with the effects of a sig- 
nificant number of psychiatric, substance- 
related, and sociodemographic variables con- 
trolled for, IUD+ adults were at significantly 
elevated risk for suicidal ideation. 
Odds ratios reflecting comparisons of 
IUD- to IUD+ inhalant users across mea- 
sures of lifetime suicide attempt, thinking 
about committing suicide, feeling like you 
wanted to die, and thinking about your own 
death were not significant (Table 3; analyses 
available upon request). 
DISCUSSION 
Study findings provide partial support 
for a positive association between severity of 
problematic inhalant involvement and suicid- 
ality. In bivariate analyses, prevalence of sui- 
cide ideation in inhalant users without IUDs 
was much higher than that reported by inhal- 
ant nonusers, but lower than the prevalence 
of suicide ideation reported by adults with 
IUDs. Multivariate logistic regression analyses, 
controlling for psychiatric, substance-related, 
and sociodemographic factors, indicated that 
IUD+ respondents had substantially greater 
odds of reporting suicidal ideation than in- 
halant nonusers. 
Bivariate analyses revealed a signifi- 
cantly greater prevalence of lifetime suicide 
attempts among IUD- respondents compared 
to inhalant nonusers and indicated that that 
IUD- men and women reported similar pro- 
portions with lifetime suicide attempts, but 
IUD+ women reported nearly twice the 
prevalence of suicide attempts as IUD+ men 
(and IUD- men and women). In multivariate 
logistic regression analyses, women were sig- 
nificantly more likely then men to attempt 
suicide but no significant main effects on sui- 
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TABLE 3 
Adjzlsted Odak Ratios Rejecting Associations Between Inhalant Use and Suicide Attempts and Ideation 
Among NESARC Respondents Completing Suicide Attempt and Ideation Items, N = 13,552 
Independent 
Variables 
Suicide Think about Feel like wanted Think about 
attempt committing suicide to die own death 





























N o t  
Antisocial ersonality 
disor &r 
Lifetime anxiety disorder 
Yes 
Lifetime alcohol use 
disorder 
N o t  
Yes 
N o t  
Yes 
N o t  
Yes 
Lifetime mood disorder 
Lifetime non-inhalant drug 
use disorder 
- - - - 
1.23 (.80-1.90) 1.40 (.96-2.05) 1.38 (.96-1.99) .93 (.67-1.30) 
1.09 (58-2.06) 2.19 (1.18-4.05) 1.99 (1.18-3.38) 1.62 (.91-2.86) 
- - - - 
.67 (.55-.81) .90 (.81-1.01) .76 (.69-.85) 1.01 (.91-1.14) 
- - - - 
.77 (.62-.95) .89 (.77-1.02) .95 (.84-1.08) 3 7  (.77-.99) 
.47 (.36-.62) .73 (.62- .87) .85 (.72-1.0) 3 0  (-69-.92) 
- - - - 
1.18 (.99-1.41) .89 (.78-1.01) 1.05 (.93-1.17) 1.22 (1.09-1.36) 
- - - - 
.91 (.72-1.15) 3 1  (.71- .93) .86 (.75- .98) .79 (.70- .90) 
1.43 (1.13-1.80) 1.02 (.86-1.22) 1.07 (.91-1.26) .89 (.77-1.02) 
- - - - 
1.09 (.90-1.32) .91 (.81-1.03) 1.13 (1.01-1.26) 1.00 (.89-1.13) 
1.38 (1.08-1.77) .94 (.81-1.09) 1.20 (1.03-1.39) 1.11 (.95-1.31) 
- - - - 
.75 (.60-.92) .88 (.76-1.02) .88 (.76-1.02) .94 (.82--1 .08) 
.63 (.51-.79) .83 (.72- .97) .79 (.68- .91) .86 (.75- .99) 
.51 (.37-.70) .72 (.61- .86) .71 (.60- .85) .87 (.72-1.05) 
- - - - 
2.32 (1.83-2.96) 2.02 (1.62-2.52) 1.58 (1.31-1.91) 1.72 (1.39-2.13) 
- - - - 
1.41 (1.18-1.69) 1.39 (1.25-1.54) 1.45 (1.32-1.59) 1.49 (1.35-1.65) 
- - - - 
1.30 (1.07-1.58) 1.31 (1.16-1.48) 1.23 (1.10-1.37) 1.18 (1.05-1.33) 
- - - - 
5.43 (4.1 1-7.19) 6.15 (5.33-7.09) 7.22 (6.32-8.25) 4.15 (3.63-4.74) 
- - - - 
1.56 (1.26-1.93) 1.51 (1.32-1.72) 1.41 (1.23-1.62) 1.26 (1.08-1.47) 
Notes. Values in bold are significant based on a 95% confidence interval that does not bound 1.0. 
All reported odds ratios were adjusted for the remaining variables listed in the far left column of the 
table. 
AOR = Adjusted odds ratio. 
IUD- refers to lifetime inhalant users without lifetime DSM-ZV inhalant abuse or dependence. 
t = reference group. 
IUD+ refers to lifetime inhalant users with DSM-IV lifetime inhalant abuse or dependence. 
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cide attempts were observed for status as a 
IUD- or IUD+ inhalant user relative to in- 
halant nonuser, As noted above, post hoc mul- 
tiple logistic regression follow-up analyses 
testing gender times inhalant-user-category 
interaction terms across lifetime suicide at- 
tempts were nonsignificant. 
Thus, our findings support a significant 
relationship between inhalant use, IUDs, and 
suicide ideation, but provide less clear find- 
ings with respect to suicide attempts. IUD- 
and IUD+ adults had lifetime suicide attempt 
prevalence rates nearly three times greater 
than inhalant nonusers in bivariate analyes, 
but inhalant use and IUDs were not related 
to suicide attempt in multivariate analyses. It 
is possible that the null findings for inhalant 
use and suicide attempts in multivariate anal- 
yses were due to the statistical procedures 
employed, which controlled comprehensively 
for the effects of psychiatric comorbidities 
commonly associated with suicide and occur- 
ring disproportionately in IUD- and IUD+ 
adults compared to inhalant nonusers ADDIN{ 
ADDIN EN.CITE.DATA (Wu & Howard, 
2007; Wu, Howard, & Pilowsky, 2008). An- 
other possibility is that IUD- and especially 
IUD+ individuals tend to use more lethal 
means for attempting suicide than non-inhal- 
ant users and were therefore not included in 
the NESARC survey if they completed sui- 
cide. Testing this hypothesis would require 
data on completed suicides among nonusers 
and IUD- and IUD+ individuals, which are 
currently unavailable. 
The causal role of inhalant use and 
IUDs in suicide attempts remains unclear 
and continued study of these associations is 
clearly needed. Further, Borges et al. (2000) 
reported disaggregated findings which sug- 
gested that the effects of substance use may 
primarily be on suicide ideation and un- 
planned suicide attempts, rather than on 
planned attempts. Mann (2003) has noted the 
role that substance-related neurotoxicity, 
particularly in the ventral prefrontal cortex, 
may play in disinhibiting aggressive behavior 
and promoting impulsive acts such as suicide 
attempts. Thus, greater specificity would be 
desirable in the assessment of specific forms 
of suicidal behavior, particularly suicide at- 
tempts. 
Particularly striking in the current 
study were the findings that nearly one-in- 
three IUD+ women had attempted suicide 
and that more than half of IUD- and three 
quarters of IUD+ women had thought about 
committing suicide and felt like 'they wanted 
to die, respectively. These results are com- 
patible with contemporary reports indicating 
that girls and women who use inhalants and/ 
or develop IUDs are at elevated risk for sui- 
cidal thoughts and attempts. For example, 
Luncheon et al. (2008) found high rates of 
inhalant use in adolescent females contem- 
plating suicide and an odds ratio of 2.6 for 
suicidal thoughts among adolescent females 
who had versus had not used inhalants. The 
investigations of Freedenthal, Vaughn, Jen- 
son, and Howard (2007) and Wilcox and An- 
thony (2004) provide further indication that 
inhalant use in females may be more strongly 
associated with suicidality than in males. 
Possible reasons for a significant asso- 
ciation of inhalant use to suicidality among 
girls and women are that inhalant use in fe- 
males may reflect a comparatively more psy- 
chiatrically troubled or antisocial profile rela- 
tive to such use in male inhalant users; may 
be attributable to self-medication with inhal- 
ants of anxious and depressive mood states 
that are observed more frequently in females 
than males (Perron et al., 2007); or that in- 
halant use may disinhibit suicide ideation and 
attempts in girls and women with low mood, 
dysthymia, and major depressive disorder, 
which they experience at disproportionately 
high levels (Howard, Balster, Cottler, Wu, & 
Vaughn, 2008; Wu et al., 2008). At a mini- 
mum, the findings suggest that treatment and 
prevention resources should be targeted to 
girls and women using inhalants. 
With regard to general profiles, it is 
notable that among persons with a history of 
low mood, IUD+ adults tend to be compara- 
tively young, unmarried, antisocial, and af- 
flicted with high rates of anxiety, mood, alco- 
hol, and non-inhalant drug use disorders 
compared to inhalant nonusers. While IUD+ 
women evidenced high levels of suicide at- 
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tempt and ideation, it is also true that nearly 
two thirds of IUD+ men report having 
thought about committing suicide and feel- 
ing like they wanted to die. The high risk 
profile that characterizes IUD+ adults (and 
IUD- adults to a lesser though still signifi- 
cant degree) has been reported in other in- 
vestigations of youth and adult inhalant users 
(Howard et al., 2008; Wu & Howard, 2007; 
Wu et al., 2008). 
This research is characterized by sev- 
eral limitations. Although data were collected 
via a structured psychiatric interview using a 
psychometrically sound instrument, they are 
based on self-report and subject to typical 
limitations of self-report data including un- 
reliable retrospective recall. Further, cross- 
sectional studies cannot establish causality. 
Thus, the etiological nature of the relation- 
ship among inhalant use, IUDs, and suicidal- 
ity cannot be determined in the present study. 
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